Winton Group LTD Rhythm Pharmaceuticals, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$8.62 - $13.9 $207,293 - $334,267	-24,048 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$11.68 - $20.72 $83,920 - $148,873	7,185 Added 42.61%	24,048 $314,000
Q2 2021 Aug 10, 2021	BUY	$18.52 - $22.55 $312,302 - $380,260	16,863 New	16,863 $330,000
Q4 2020 Feb 12, 2021	SELL	$21.17 - $32.61 $278,576 - $429,114	-13,159 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$18.13 - $30.61 $238,572 - $402,796	13,159 New	13,159 $285,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.